BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31534171)

  • 1. Flow cytometric detection of leukemic blasts in cerebrospinal fluid predicts risk of relapse in childhood acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology study.
    Thastrup M; Marquart HV; Levinsen M; Grell K; Abrahamsson J; Albertsen BK; Frandsen TL; Harila-Saari A; Lähteenmäki PM; Niinimäki R; Pronk CJ; Ulvmoen A; Vaitkevičienė G; Taskinen M; Schmiegelow K;
    Leukemia; 2020 Feb; 34(2):336-346. PubMed ID: 31534171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukemic blasts are present at low levels in spinal fluid in one-third of childhood acute lymphoblastic leukemia cases.
    Levinsen M; Marquart HV; Groth-Pedersen L; Abrahamsson J; Albertsen BK; Andersen MK; Frandsen TL; Harila-Saari A; Pronk C; Ulvmoen A; Vaitkevičienė G; Lähteenmäki PM; Niinimäki R; Taskinen M; Jeppesen M; Schmiegelow K;
    Pediatr Blood Cancer; 2016 Nov; 63(11):1935-42. PubMed ID: 27447373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absolute count of leukemic blasts in cerebrospinal fluid as detected by flow cytometry is a relevant prognostic factor in children with acute lymphoblastic leukemia.
    Popov A; Henze G; Verzhbitskaya T; Roumiantseva J; Lagoyko S; Khlebnikova O; Streneva O; Bidanov O; Tsaur G; Inaba H; Karachunskiy A; Fechina L
    J Cancer Res Clin Oncol; 2019 May; 145(5):1331-1339. PubMed ID: 30840196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow Cytometric Detection of Malignant Blasts in Cerebrospinal Fluid: A Biomarker of Central Nervous System Involvement in Childhood Acute Lymphoblastic Leukemia.
    Thastrup M; Marquart HV; Schmiegelow K
    Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of central nervous system involvement in childhood acute lymphoblastic leukemia by cytomorphology and flow cytometry of the cerebrospinal fluid.
    Ranta S; Nilsson F; Harila-Saari A; Saft L; Tani E; Söderhäll S; Porwit A; Hultdin M; Noren-Nyström U; Heyman M
    Pediatr Blood Cancer; 2015 Jun; 62(6):951-6. PubMed ID: 25545289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric analysis of cerebrospinal fluid improves detection of leukaemic blasts in infants with acute lymphoblastic leukaemia.
    Thastrup M; Marquart HV; Levinsen M; Modvig S; Abrahamsson J; Albertsen BK; Frost BM; Harila-Saari A; Pesola J; Ulvmoen A; Wojcik DM; Taskinen M; Hoffmann M; Lausen B; Schmiegelow K;
    Br J Haematol; 2021 Oct; 195(1):119-122. PubMed ID: 34396501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of CNS 2 cerebrospinal fluid status post-induction in pediatric and adolescent patients with acute lymphoblastic leukemia.
    Gurunathan A; Desai AV; Bailey LC; Li Y; Choi JK; Rheingold SR
    Pediatr Blood Cancer; 2019 Jan; 66(1):e27433. PubMed ID: 30207055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of conventional cytomorphology, flow cytometry immunophenotyping, and automated cell counting of CSF for detection of CNS involvement in acute lymphoblastic leukemia.
    Jaime-Pérez JC; Borrego-López MF; Jiménez-Castillo RA; Méndez-Ramírez N; Salazar-Riojas R; Fernández LT; Gómez-Almaguer D
    Int J Lab Hematol; 2018 Apr; 40(2):169-174. PubMed ID: 29115725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapse risk following truncation of pegylated asparaginase in childhood acute lymphoblastic leukemia.
    Gottschalk Højfeldt S; Grell K; Abrahamsson J; Lund B; Vettenranta K; Jónsson ÓG; Frandsen TL; Wolthers BO; Marquart HV; Vaitkeviciene G; Lepik K; Heyman M; Schmiegelow K; Albertsen BK
    Blood; 2021 Apr; 137(17):2373-2382. PubMed ID: 33150360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of blasts in the cerebrospinal fluid without pleiocytosis or a traumatic lumbar puncture in children with acute lymphoblastic leukemia: experience of the Dutch Childhood Oncology Group.
    ; te Loo DM; Kamps WA; van der Does-van den Berg A; van Wering ER; de Graaf SS
    J Clin Oncol; 2006 May; 24(15):2332-6. PubMed ID: 16710032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of central nervous system relapse of pediatric acute lymphoblastic leukemia: Impact of routine cytological CSF analysis at the time of intrathecal chemotherapy.
    Gassas A; Krueger J; Alvi S; Sung L; Hitzler J; Lieberman L
    Pediatr Blood Cancer; 2014 Dec; 61(12):2215-7. PubMed ID: 25212396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posterior reversible encephalopathy syndrome in children with acute lymphoblastic leukemia: Clinical characteristics, risk factors, course, and outcome of disease.
    Anastasopoulou S; Eriksson MA; Heyman M; Wang C; Niinimäki R; Mikkel S; Vaitkevičienė GE; Johannsdottir IM; Myrberg IH; Jonsson OG; Als-Nielsen B; Schmiegelow K; Banerjee J; Harila-Saari A; Ranta S
    Pediatr Blood Cancer; 2019 May; 66(5):e27594. PubMed ID: 30592147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial.
    Nielsen SN; Grell K; Nersting J; Abrahamsson J; Lund B; Kanerva J; Jónsson ÓG; Vaitkeviciene G; Pruunsild K; Hjalgrim LL; Schmiegelow K
    Lancet Oncol; 2017 Apr; 18(4):515-524. PubMed ID: 28258828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid analysis by 8-color flow cytometry in children with acute lymphoblastic leukemia.
    Gabelli M; Disarò S; Scarparo P; Francescato S; Zangrando A; Valsecchi MG; Putti MC; Basso G; Buldini B
    Leuk Lymphoma; 2019 Nov; 60(11):2825-2828. PubMed ID: 31018745
    [No Abstract]   [Full Text] [Related]  

  • 15. Outcome after first relapse in children with acute lymphoblastic leukemia: a population-based study of 315 patients from the Nordic Society of Pediatric Hematology and Oncology (NOPHO).
    Schroeder H; Garwicz S; Kristinsson J; Siimes MA; Wesenberg F; Gustafsson G
    Med Pediatr Oncol; 1995 Nov; 25(5):372-8. PubMed ID: 7674994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of occult cerebrospinal fluid involvement during maintenance therapy identifies a group of children with acute lymphoblastic leukemia at high risk for relapse.
    Martínez-Laperche C; Gómez-García AM; Lassaletta Á; Moscardó C; Vivanco JL; Molina J; Fuster JL; Couselo JM; de Toledo JS; Bureo E; Madero L; Ramírez M
    Am J Hematol; 2013 May; 88(5):359-64. PubMed ID: 23468276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of Fluorescence In Situ Hybridization on Cerebrospinal Fluid Cytospins for the Detection of Residual Leukemic Cells in Patients With Childhood Acute Lymphoblastic Leukemia.
    Hwang SM; Park HS; Park S; Kim SM; Hong KT; Chang YH; Lee DS
    Am J Clin Pathol; 2019 Mar; 151(4):416-423. PubMed ID: 30561492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proportion and Pattern of Central Nervous System Involvement in Acute Leukemia on Diagnosis.
    Yeasmin S; Rashid MH; Debnath MR; Rashid MM
    Mymensingh Med J; 2022 Jan; 31(1):55-60. PubMed ID: 34999680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WT1 mRNA in cerebrospinal fluid associated with relapse in pediatric lymphoblastic leukemia.
    Ramirez O; Linares A; Trujillo ML; Caminos JE
    J Pediatr Hematol Oncol; 2003 Jun; 25(6):453-8. PubMed ID: 12794523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow-cytometric minimal residual disease monitoring in blood predicts relapse risk in pediatric B-cell precursor acute lymphoblastic leukemia in trial AIEOP-BFM-ALL 2000.
    Schumich A; Maurer-Granofszky M; Attarbaschi A; Pötschger U; Buldini B; Gaipa G; Karawajew L; Printz D; Ratei R; Conter V; Schrappe M; Mann G; Basso G; Dworzak MN;
    Pediatr Blood Cancer; 2019 May; 66(5):e27590. PubMed ID: 30561169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.